Shenshen Yang

1.7k total citations
35 papers, 1.2k citations indexed

About

Shenshen Yang is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Shenshen Yang has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Pharmacology and 10 papers in Pharmacology. Recurrent topics in Shenshen Yang's work include Ginseng Biological Effects and Applications (6 papers), Berberine and alkaloids research (6 papers) and Pharmacological Effects of Natural Compounds (5 papers). Shenshen Yang is often cited by papers focused on Ginseng Biological Effects and Applications (6 papers), Berberine and alkaloids research (6 papers) and Pharmacological Effects of Natural Compounds (5 papers). Shenshen Yang collaborates with scholars based in China, United States and Norway. Shenshen Yang's co-authors include Xia Lin, Yuqiang Miao, Xing Tang, Wei Chen, Yuling Qiu, Haiyang Yu, Tao Wang, Xiaomei Bao, Kailong Wang and Yubo Li and has published in prestigious journals such as The FASEB Journal, Molecules and Journal of Econometrics.

In The Last Decade

Shenshen Yang

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenshen Yang China 17 500 362 309 203 153 35 1.2k
Gurdarshan Singh India 22 549 1.1× 215 0.6× 232 0.8× 92 0.5× 181 1.2× 73 1.4k
R. Rajendran India 4 573 1.1× 261 0.7× 331 1.1× 111 0.5× 67 0.4× 10 1.6k
Chunli Zheng China 26 972 1.9× 315 0.9× 458 1.5× 106 0.5× 163 1.1× 60 1.9k
Xiaohui Wei China 16 580 1.2× 128 0.4× 189 0.6× 72 0.4× 97 0.6× 42 1.2k
Mohammad Ahmed Khan India 20 473 0.9× 160 0.4× 110 0.4× 72 0.4× 148 1.0× 96 1.4k
Xueqin Ma China 27 797 1.6× 148 0.4× 230 0.7× 69 0.3× 133 0.9× 92 1.7k
Hao Huang China 22 684 1.4× 180 0.5× 207 0.7× 67 0.3× 57 0.4× 75 1.5k
Hussain Ali Pakistan 24 440 0.9× 136 0.4× 260 0.8× 378 1.9× 104 0.7× 43 1.7k
Aniko M Sólyom United States 18 550 1.1× 278 0.8× 623 2.0× 74 0.4× 95 0.6× 28 1.7k
Katarína Bauerová Slovakia 20 538 1.1× 183 0.5× 255 0.8× 82 0.4× 78 0.5× 80 1.4k

Countries citing papers authored by Shenshen Yang

Since Specialization
Citations

This map shows the geographic impact of Shenshen Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenshen Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenshen Yang more than expected).

Fields of papers citing papers by Shenshen Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenshen Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenshen Yang. The network helps show where Shenshen Yang may publish in the future.

Co-authorship network of co-authors of Shenshen Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shenshen Yang. A scholar is included among the top collaborators of Shenshen Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenshen Yang. Shenshen Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Bohan, Bing Xie, Mengjiao Zhou, et al.. (2025). Recent advances in oral hydrogel drug delivery system for disease treatment. Chinese Chemical Letters. 111695–111695.
2.
Wei, Shizhong, et al.. (2025). Hydrothermal synthesis and bifunctional electrocatalytic properties of N and Co co-doped MoS2 for water splitting. Tungsten. 7(3). 511–524. 4 indexed citations
3.
Xu, Zhenghu, Shenshen Yang, Bohan Chen, et al.. (2025). Carrier-free nanoparticles—new strategy of improving druggability of natural products. Journal of Nanobiotechnology. 23(1). 108–108. 13 indexed citations
4.
Yang, Shenshen, et al.. (2025). Cancer network pharmacology: multi-network regulatory mechanisms and future directions. Medical Oncology. 42(7). 255–255. 2 indexed citations
5.
Wang, Songsong, Qiang Jia, Xiaoli Liu, et al.. (2025). Hyperoside modulates bile acid and fatty acid metabolism, presenting a potentially promising treatment for non-alcoholic fatty liver disease. Journal of Advanced Research. 80. 759–773. 4 indexed citations
6.
Li, Xiaomeng, Buda Su, Hui Liu, et al.. (2024). Construction of a physiologically based pharmacokinetic model of paclobutrazol and exposure estimation in the human body. Toxicology. 505. 153841–153841. 1 indexed citations
7.
Han, Xiao, Siqi Zhang, Shenshen Yang, et al.. (2024). The role of NCAPH in cancer treatment. Cellular Signalling. 121. 111262–111262. 4 indexed citations
8.
Yin, Shuangshuang, Shenshen Yang, Jia Lu, et al.. (2021). Cyclin-dependent kinase 1 as a potential target for lycorine against hepatocellular carcinoma. Biochemical Pharmacology. 193. 114806–114806. 21 indexed citations
9.
Fan, Simiao, et al.. (2020). ASBT(SLC10A2): A promising target for treatment of diseases and drug discovery. Biomedicine & Pharmacotherapy. 132. 110835–110835. 61 indexed citations
10.
Yang, Shenshen, Kailong Wang, Xiaomei Bao, et al.. (2019). Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 120. 109543–109543. 131 indexed citations
11.
Yang, Shenshen, et al.. (2018). [Pharmacokinetics mechanism of ABC efflux proteins-mediated seven features of compatibility].. PubMed. 43(4). 676–683. 3 indexed citations
12.
Wang, Yuan, et al.. (2016). Compounds with Estrogen-like Effects from Epimedii Folium Based on Cell Sorption and Molecular Docking. 22(20). 66. 1 indexed citations
13.
Zhang, Keru, Hongxia Yu, Qingqing Luo, et al.. (2013). Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension. European Journal of Pharmaceutics and Biopharmaceutics. 85(3). 1285–1292. 96 indexed citations
14.
Lin, Xia, Bo Zhang, Keru Zhang, et al.. (2012). Preclinical evaluations of norcantharidin-loaded intravenous lipid microspheres with low toxicity. Expert Opinion on Drug Delivery. 9(12). 1449–1462. 21 indexed citations
15.
Yang, Shenshen, Keru Zhang, Xia Lin, et al.. (2012). Pharmacokinetic comparisons of single herb extract of Fufang Danshen preparation with different combinations of its constituent herbs in rats. Journal of Pharmaceutical and Biomedical Analysis. 67-68. 77–85. 36 indexed citations
16.
Chen, Wei, Yuqiang Miao, Shenshen Yang, et al.. (2011). Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of berberine in rats. Drug Development and Industrial Pharmacy. 38(1). 104–110. 50 indexed citations
17.
Guan, Tingting, Yuqiang Miao, Lishuang Xu, et al.. (2011). Injectable nimodipine-loaded nanoliposomes: Preparation, lyophilization and characteristics. International Journal of Pharmaceutics. 410(1-2). 180–187. 54 indexed citations
18.
Chen, Wei, et al.. (2011). Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats. AAPS PharmSciTech. 12(2). 705–711. 295 indexed citations
19.
Lin, Xia, Shenshen Yang, Jingxin Gou, et al.. (2011). A novel risperidone-loaded SAIB–PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo. Journal of Materials Science Materials in Medicine. 23(2). 443–455. 47 indexed citations
20.
Zhang, Wenjun, et al.. (2009). Technology for improving the bioavailability of small molecules extracted from traditional Chinese medicines. Expert Opinion on Drug Delivery. 6(11). 1247–1259. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026